Urinary Pharmacokinetic and Pharmacodynamic Profiles of Fosfomycin against Extended-Spectrum β-Lactamase-Producing Escherichia coli with Canine Ex Vivo Modeling: A Pilot Study

Fosfomycin is a candidate drug for extended-spectrum β-lactamase (ESBL)-producing bacteria, but its efficacy is yet to be investigated in dogs. This study investigated the urinary pharmacokinetic/pharmacodynamic (PK/PD) profile of fosfomycin orally administered at 80 mg/kg to six healthy dogs to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Kazuki, Shimizu, Takae, Kawaguchi, Koji, Furuhashi, Takeshi, Ishihara, Genki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277591/
https://www.ncbi.nlm.nih.gov/pubmed/32380640
http://dx.doi.org/10.3390/antibiotics9050230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277591/
https://www.ncbi.nlm.nih.gov/pubmed/32380640
http://dx.doi.org/10.3390/antibiotics9050230

Ejemplares similares